SciELO - Scientific Electronic Library Online

 
vol.14 número1¿Cómo informaron los medios de comunicación web sobre el brote de síndrome de Guillain-Barré en Perú?Rabdomiosarcoma paratesticular: Reporte de caso y revisión de la literatura índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo

versão impressa ISSN 2225-5109versão On-line ISSN 2227-4731

Resumo

SALAS-BOLANOS, Rosa Alejandra; SEVILLA-RODRIGUEZ, David Ezequiel  e  ARROYO-SANCHEZ, Abel Salvador. Use of antirheumatic drugs in covid-19 from hydroxychloroquine to anakinra through tocilizumab and baricitinib: A review of the literature. Rev. Cuerpo Med. HNAAA [online]. 2021, vol.14, n.1, pp.52-63. ISSN 2225-5109.  http://dx.doi.org/10.35434/rcmhnaaa.2021.141.821.

We are currently in a global pandemic caused by the coronavirus 2019 or COVID- 19, presenting different challenges for the health system due to the fact that there is still no vaccine or a treatment that has proven its effectiveness in its entirety, being the management current preventive and supportive. Therefore, this review will study the most prominent antirheumatic drugs that have a probable pharmacological effect, such as hydroxychloroquine, tocilizumab, anakinra and baricitinib, against COVID-19. It is expected that they will provide support for future treatments. and research on the disease.

Palavras-chave : COVID-19; hydroxychloroquine; tocilizumab; anakinra; baricitinib; antirheumatic agents.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )